Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes

Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes

Thumbnail Image
Download
Name

jem_20221847.pdf

Description
Published version
Size

9.07 MB

Format

Adobe PDF

Checksum (MD5)

b96ce9d9fc8e386e41272c3907ec4366

Author(s)
Lei, Pin-Ji
•
Pereira, Ethel R
•
Andersson, Patrik
•
Amoozgar, Zohreh
•
Van Wijnbergen, Jan Willem
•
O’Melia, Meghan J
•
Zhou, Hengbo
•
Chatterjee, Sampurna
•
Ho, William W
•
Posada, Jessica M
more
Date Issued
September 4, 2023
Journal
Journal of Experimental Medicine
Publisher
Rockefeller University Press
Citation
Pin-Ji Lei, Ethel R. Pereira, Patrik Andersson, Zohreh Amoozgar, Jan Willem Van Wijnbergen, Meghan J. O’Melia, Hengbo Zhou, Sampurna Chatterjee, William W. Ho, Jessica M. Posada, Ashwin S. Kumar, Satoru Morita, Lutz Menzel, Charlie Chung, Ilgin Ergin, Dennis Jones, Peigen Huang, Semir Beyaz, Timothy P. Padera; Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes. J Exp Med 4 September 2023; 220 (9): e20221847.
Version
Final published version
Abstract
Tumor-draining lymph nodes (TDLNs) are important for tumor antigen–specific T cell generation and effective anticancer immune responses. However, TDLNs are often the primary site of metastasis, causing immune suppression and worse outcomes. Through cross-species single-cell RNA-Seq analysis, we identified features defining cancer cell heterogeneity, plasticity, and immune evasion during breast cancer progression and lymph node metastasis (LNM). A subset of cancer cells in the lymph nodes exhibited elevated MHC class II (MHC-II) gene expression in both mice and humans. MHC-II+ cancer cells lacked costimulatory molecule expression, leading to regulatory T cell (Treg) expansion and fewer CD4+ effector T cells in TDLNs. Genetic knockout of MHC-II reduced LNM and Treg expansion, while overexpression of the MHC-II transactivator, Ciita, worsened LNM and caused excessive Treg expansion. These findings demonstrate that cancer cell MHC-II expression promotes metastasis and immune evasion in TDLNs.
Terms of Use
Creative Commons Attribution-NonCommercial-ShareAlike
https://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://dspace.mit.edu/handle/1721.1/167880
DOI of Published Version
https://doi.org/10.1084/jem.20221847
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.